Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Research & Development (2024 - 2025)

Historic Research & Development for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $67.9 million.

  • Kura Oncology's Research & Development rose 6282.94% to $67.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year change of. This contributed to the annual value of $170.0 million for FY2024, which is 4749.6% up from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Research & Development is $67.9 million, which was up 6282.94% from $62.8 million recorded in Q2 2025.
  • Kura Oncology's 5-year Research & Development high stood at $67.9 million for Q3 2025, and its period low was $36.3 million during Q1 2024.